Literature DB >> 19301649

pSM155 and pSM30 vectors for miRNA and shRNA expression.

Junzhu Wu1, Akua N Bonsra, Guangwei Du.   

Abstract

MicroRNAs (miRNAs) have key roles in diverse regulatory pathways, including control of developmental timing, cell differentiation, apoptosis, cell proliferation, and organ development. miRNAs regulate gene function through a process termed RNA interference (RNAi), which is a highly conserved intracellular mechanism that regulates posttranscriptional gene silencing. RNAi is triggered by double-stranded small interfering RNAs (siRNAs), which can be processed from small hairpin RNAs (shRNAs) generated from an expression vector. In some recently described vectors, the siRNAs are expressed from synthetic stem-loop precursors of microRNAs (miRNAs) driven by polymerase II promoters. We have reported new RNAi vectors, designated pSM155 and pSM30, that take into consideration miRNA processing and RNA splicing by placing the miRNA-based artificial miRNA expression cassettes inside of synthetic introns. Like the original miRNA vectors, these pSM155 and pSM30 constructs can efficiently downregulate the expression of their target genes. Moreover, the expression of a coexpressed fluorescent marker, EGFP, is substantially improved by this new design. The new vectors can also be used to express natural miRNAs and label cells expressing these miRNAs. These RNAi vectors thus provide new tools for gene suppression and miRNA expression. We describe in this chapter the protocols for selecting and cloning artificial and natural miRNAs (or shRNAs), evaluating their efficiency in downregulating gene expression, and also discuss the potential applications of these vectors.

Mesh:

Substances:

Year:  2009        PMID: 19301649     DOI: 10.1007/978-1-60327-547-7_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Regulation of the Glycine Transporter GLYT1 by microRNAs.

Authors:  Esperanza Jiménez; Dolores Piniella; Cecilio Giménez; Francisco Zafra
Journal:  Neurochem Res       Date:  2021-01-23       Impact factor: 3.996

2.  Effect of Xpcl1 activation and p27(Kip1) loss on gene expression in murine lymphoma.

Authors:  Daniel A Kuppers; Harry C Hwang; Aimee L Jackson; Peter S Linsley; Bruce E Clurman; Matthew L Fero
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

3.  Synthetic Pre-miRNA-Based shRNA as Potent RNAi Triggers.

Authors:  Kazuya Terasawa; Kazuharu Shimizu; Gozoh Tsujimoto
Journal:  J Nucleic Acids       Date:  2011-07-12

4.  Artificial MiRNA Knockdown of Platelet Glycoprotein lbα: A Tool for Platelet Gene Silencing.

Authors:  Tim Thijs; Katleen Broos; Stefaan J Soenen; Aline Vandenbulcke; Karen Vanhoorelbeke; Hans Deckmyn; Isabelle I Salles-Crawley
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

5.  A simplified system for the effective expression and delivery of functional mature microRNAs in mammalian cells.

Authors:  Jiaming Fan; Yixiao Feng; Ruyi Zhang; Wenwen Zhang; Yi Shu; Zongyue Zeng; Shifeng Huang; Linghuan Zhang; Bo Huang; Di Wu; Bo Zhang; Xi Wang; Yan Lei; Zhenyu Ye; Ling Zhao; Daigui Cao; Lijuan Yang; Xian Chen; Bin Liu; William Wagstaff; Fang He; Xiaoxing Wu; Jing Zhang; Jennifer Moriatis Wolf; Michael J Lee; Rex C Haydon; Hue H Luu; Ailong Huang; Tong-Chuan He; Shujuan Yan
Journal:  Cancer Gene Ther       Date:  2019-06-20       Impact factor: 5.987

6.  Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity.

Authors:  Xiao-yan Liu; Qiu-su Tang; Hong-chao Chen; Xiao-ling Jiang; Hong Fang
Journal:  Int J Biol Sci       Date:  2013-06-12       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.